+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
From
From
From
From
From
Acetyl-CoA carboxylase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Acetyl-CoA carboxylase inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Non-Injectable Insulin - Product Thumbnail Image

Non-Injectable Insulin

  • Report
  • January 2020
  • 54 Pages
  • Global
From
Parathyroid Hormone Market Report 2025 - Product Thumbnail Image

Parathyroid Hormone Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Bioengineered Protein Drugs Market Report 2025 - Product Thumbnail Image

Bioengineered Protein Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator